RE Pounder

404 total citations
32 papers, 294 citations indexed

About

RE Pounder is a scholar working on Surgery, Gastroenterology and Immunology. According to data from OpenAlex, RE Pounder has authored 32 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 7 papers in Gastroenterology and 7 papers in Immunology. Recurrent topics in RE Pounder's work include Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (5 papers) and Inflammatory Bowel Disease (5 papers). RE Pounder is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (5 papers) and Inflammatory Bowel Disease (5 papers). RE Pounder collaborates with scholars based in United Kingdom. RE Pounder's co-authors include C. J. Gavey, AJ Wakefield, Scott Montgomery, CU Nwokolo, S B Rosalki, Javaid Subhani, S Lanzon-Miller, A. M. Sawyerr, R.G.G. Russell and Owen Epstein and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

RE Pounder

29 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RE Pounder United Kingdom 9 160 110 67 49 49 32 294
Beint S. Bentsen Norway 10 148 0.9× 135 1.2× 86 1.3× 34 0.7× 99 2.0× 26 445
R. Burakoff United States 13 151 0.9× 149 1.4× 45 0.7× 53 1.1× 21 0.4× 28 373
C Ricour France 12 290 1.8× 62 0.6× 47 0.7× 75 1.5× 60 1.2× 39 526
Rosa Pettinato Italy 11 66 0.4× 69 0.6× 70 1.0× 26 0.5× 46 0.9× 20 512
Martin Claßen Germany 10 144 0.9× 62 0.6× 28 0.4× 47 1.0× 24 0.5× 50 340
Jorunn Bratlie Norway 8 162 1.0× 225 2.0× 166 2.5× 51 1.0× 41 0.8× 10 408
A Sojo Spain 8 136 0.8× 133 1.2× 105 1.6× 100 2.0× 32 0.7× 13 317
Ivo Rotkvić Croatia 12 171 1.1× 88 0.8× 133 2.0× 27 0.6× 111 2.3× 32 374
R. W. Stockbruegger Sweden 9 216 1.4× 155 1.4× 22 0.3× 49 1.0× 31 0.6× 10 337
MS Murphy United Kingdom 13 239 1.5× 94 0.9× 105 1.6× 65 1.3× 126 2.6× 20 450

Countries citing papers authored by RE Pounder

Since Specialization
Citations

This map shows the geographic impact of RE Pounder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Pounder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Pounder more than expected).

Fields of papers citing papers by RE Pounder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RE Pounder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Pounder. The network helps show where RE Pounder may publish in the future.

Co-authorship network of co-authors of RE Pounder

This figure shows the co-authorship network connecting the top 25 collaborators of RE Pounder. A scholar is included among the top collaborators of RE Pounder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RE Pounder. RE Pounder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Anthony, et al.. (1999). Changing incidence of columnar-lined (Barrett's) oesophagus (CLO) in the UK. UCL Discovery (University College London). 8 indexed citations
2.
Subhani, Javaid, et al.. (1998). Antineutrophil cytoplasmic autoantibodies (ANCA) in monozygotic twins discordant for inflammatory bowel disease (IBD). Gastroenterology. 114. A1093–A1093. 1 indexed citations
3.
Pounder, RE, et al.. (1998). Effect of different test meals on the lara system 13C urea breath test in H. Pylori infected volunteers. Gastroenterology. 114. A331–A331. 2 indexed citations
4.
Montgomery, Scott, et al.. (1998). Concurrent measles & mumps epidemics in iceland are a risk for later inflammatory bowel disease. Gastroenterology. 114. A1043–A1043. 2 indexed citations
5.
Michaeli, D, et al.. (1996). The effect of gastrin-17 and glycine-extended gastrin-17 on the proliferation of liver embryo and hepatocellular carcinoma cell lines.. UCL Discovery (University College London). 1 indexed citations
6.
Montgomery, Scott, et al.. (1995). Measles vaccination: A risk factor for inflammatory bowel disease?. Gastroenterology. 108(4). A928–A928. 48 indexed citations
7.
Pounder, RE. (1995). Measles virus and Crohn's disease: research from the Royal Free Hospital in London.. PubMed. 30 Suppl 8. 48–51. 9 indexed citations
8.
Rosalki, S B, et al.. (1995). Inter‐individual and intra‐individual variability of ethanol concentration‐time profiles: comparison of ethanol ingestion before or after an evening meal.. British Journal of Clinical Pharmacology. 40(4). 387–392. 39 indexed citations
9.
Driscoll, Richard, et al.. (1995). Genetics vs. environment in inflammatory bowel disease: Concordance rates in 130 twin pairs. Gastroenterology. 108(4). A928–A928. 1 indexed citations
10.
Thrasivoulou, Christopher, et al.. (1995). Indomethacin-induced jejunal villous contraction and microvascular occulusion: A detailed morphological study. Gastroenterology. 108(4). A772–A772. 1 indexed citations
11.
Chitolie, A, et al.. (1993). TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND FACTOR-VII IN INFLAMMATORY BOWEL-DISEASE (IBD). UCL Discovery (University College London). 1 indexed citations
12.
Gavey, C. J., et al.. (1990). Tolerance During 8 Days of High-Dose H2-Blockade: Placebo Controlled Studies of 24 Hour Acidity and Gastrin. Clinical Science. 78(s22). 12P–12P. 32 indexed citations
13.
Nwokolo, CU, et al.. (1990). Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.. Alimentary Pharmacology & Therapeutics. 4 Suppl 1. 75–83. 11 indexed citations
14.
Nwokolo, CU & RE Pounder. (1990). D‐penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.. British Journal of Clinical Pharmacology. 30(4). 648–650.
15.
Pounder, RE, et al.. (1988). THE DETECTION OF CAMPYLOBACTER-PYLORIDIS (CP) IN GASTRIC BIOPSIES - A COMPARATIVE-STUDY OF HISTOLOGY AND THE CLO TEST. UCL Discovery (University College London). 2 indexed citations
16.
Pounder, RE. (1986). Pharmacological control of human gastric acid secretion.. PubMed. 62 Suppl 2. 21–5. 1 indexed citations
17.
Pounder, RE. (1979). Has cimetidine revolutionised the medical treatment of peptic ulceration?. PubMed. 33(5). 367–70.
18.
Pounder, RE, et al.. (1978). Reduction of intragastric acidity in duodenal ulcer. Cimetidine or surgery. Acta gastro-enterologica belgica. 41(7-8). 458–462. 1 indexed citations
19.
Pounder, RE. (1978). Six years of H2-antagonists.. Acta gastro-enterologica belgica. 41(7-8). 401–408. 1 indexed citations
20.
Pounder, RE, et al.. (1975). Proceedings: New histamine H2-receptor antagonist inhibits food-stimulated gastric acid secretion.. PubMed. 16(5). 397–397. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026